Uxin (UXIN) EBITDA (2017 - 2026)

Uxin (UXIN) has reported EBITDA for 10 consecutive years, with -$5.0 million the latest figure, recorded in Q1 2026.

• For the quarter ending Q1 2026, EBITDA fell 308.04% year-over-year to -$5.0 million; the trailing twelve-month figure through Mar 2026 stood at -$11.9 million (down 72.41% YoY), and the FY2025 full-year result was -$8.3 million, up 25.21% from the prior year.
• EBITDA slipped to -$5.0 million in Q1 2026 per UXIN's latest filing, from -$3.9 million in the prior quarter.
• Across five years, EBITDA topped out at $273000.0 in Q4 2024 and bottomed at -$17.3 million in Q1 2022.
• Historically, EBITDA has averaged -$6.3 million across 5 years, with a median of -$5.5 million in 2024.
• The sharpest annual moves came in 2024 and 2025: EBITDA soared 104.43% in 2024, then slumped 1525.64% in 2025.
• Over 5 years, EBITDA stood at -$10.7 million in 2022, then surged by 42.58% to -$6.2 million in 2023, then jumped by 104.43% to $273000.0 in 2024, then plunged by 1525.64% to -$3.9 million in 2025, then decreased by 27.8% to -$5.0 million in 2026.
• According to Business Quant data, EBITDA over the past three periods registered -$5.0 million, -$3.9 million, and -$739000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.